质子治疗市场（按安装类型、适应症和地区划分）

质子治疗市场在 2025 年的估值为 35.281 亿美元，预计到 2032 年将达到 83.02 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 13.0%。

质子治疗是一种放射疗法，利用高功率治疗癌症和某些非癌性肿瘤。 X 光放射线治疗长期以来一直用于治疗癌细胞和癌细胞等疾病。质子治疗利用带正电粒子（质子）的能量。它不仅用于治疗恶性肿瘤，还用于治疗非癌性肿瘤。质子治疗应用于治疗疾病或与手术或化疗等其他治疗方法结合使用。当癌症在定期 X 光照射后持续存在或復发时，可以使用质子治疗。质子治疗有时用于治疗多种癌症，包括脑瘤、肉瘤、摄护腺癌、儿童癌症和胰臟癌。这种治疗方法可以精确地将高能量辐射递送到目标癌症或癌细胞。预计癌症研究资金的增加将为市场参与企业提供有利可图的成长机会。此外，提供质子治疗的医疗机构数量不断增加也有望推动市场成长。

市场动态

主要市场参与企业正专注于采取合作和收购等成长策略，预计将推动全球质子治疗市场的成长。癌症患者和医疗机构数量的增加预计将推动市场成长。例如，2022年8月，医疗科技公司Ion Beam Applications (IBA)宣布已与多学科医疗机构Apollo Hospitals Enterprise Ltd (AHEL)签署合作协议，为IBA在亚洲的客户提供质子治疗培训和教育计画。

本次调查的主要特点

• 本研究报告对全球质子治疗市场进行了详细分析，提供了预测期 2025 年至 2032 年的市场规模（百万美元）和年复合成长率（CAGR），以 2024 年为基准年。
• 它揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球质子治疗市场的关键公司进行了概述。
• 本研究报告介绍的主要企业包括日立、Ion Beam Applications SA、Mevion Medical Systems、三菱电机株式会社、Provision Healthcare、ProTom International、工业、瓦里安医疗系统、Optivus Proton Therapy, Inc. 和 Advanced Oncotherapy plc。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、成长策略、市场扩张和行销策略做出明智的决策。
• 全球质子治疗市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 透过全球质子治疗市场分析中使用的各种策略矩阵，相关人员将更容易做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 市场机会
• 影响分析
• 最新产品发布
• 流行病学
• 合併、收购和合作
• 监管情景
• PEST分析

4. 2020 年至 2032 年全球质子治疗市场（依安装类型）

• 介绍
• 单人房
• 多间客房

5. 全球质子治疗市场（依适应症划分），2020 年至 2032 年

• 介绍
• 头颈癌
• 肉瘤
• 儿童癌症
• 胃肠道癌症
• 摄护腺癌
• 肺癌

6. 2020 年至 2032 年全球质子治疗市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 中部非洲
  • 北非

第七章 竞争态势

• 公司简介
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Provision Healthcare
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • Advanced Oncotherapy plc.

第 8 章 章节

• 参考
• 调查方法

Proton Therapy Market is estimated to be valued at USD 3,528.1 Mn in 2025 and is expected to reach USD 8,300.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2032.

Proton therapy is a type of radiation therapy that uses high-power energy to treat cancer and certain non-cancerous tumors. Radiation therapy using X-rays has long been used to treat the conditions such as tumor cell or cancer cells. Proton therapy uses energy from positively charged particles (protons). It is used to treat non-cancerous tumors as well as malignancy. Proton therapy must be used to treat the illness, or it must be combined with other treatments like surgery and chemotherapy. If the cancer is still present or returns after conventional X-ray radiation, proton treatment may also be employed. Proton therapy is sometimes used to treat various cancers such as brain tumors, sarcoma, prostate cancer, pediatric cancer, and pancreatic cancer. The therapy utilizes a precision dose of high-energy radiation in the target cancer cells and tumor cells. Increasing funding for cancer research is expected to offer lucrative growth opportunities for market players. Furthermore, the increasing number of healthcare facilities offering proton therapy is also expected to drive market growth.

Market Dynamics

The key market players are focused on adopting growth strategies, such as collaboration and acquisitions, which is anticipated to fuel the global proton therapy market growth. The increasing number of cancer patients and healthcare facilities is expected to boost the market growth. For instance, in August 2022, IBA (Ion Beam Applications), a medical technology company, announced that it had signed a collaboration agreement with Apollo Hospitals Enterprise Ltd (AHEL), a multispecialty health care unit, to provide proton therapy training and education programs for IBA customers in Asia.

Key features of the study

• This report provides an in-depth analysis of the global proton therapy market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global proton therapy market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies.
• The key companies covered as a part of this study include Hitachi Ltd., Ion Beam Applications SA, Mevion Medical Systems, Mitsubishi Electric Corporation, Provision Healthcare, ProTom International, Sumitomo Heavy Industries, Varian Medical Systems, Optivus Proton Therapy, Inc., and Advanced Oncotherapy plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global proton therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proton therapy market.

Market Segmentation

• Global Proton Therapy Market, By Set-up Type
  • Single Room
  • Multiple Room
• Global Proton Therapy Market, By Indication
  • Head & Neck Cancer
  • Sarcoma
  • Pediatric Cancer
  • Gastro-intestinal Cancer
  • Prostate Cancer
  • Lung Cancer
• Global Proton Therapy Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Provision Healthcare
  • Protom International
  • Sumitomo Heavy Industries
  • Varian Medical Systems
  • Optivus Proton Therapy, Inc.
  • Advanced Oncotherapy plc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Setup Type
  • Market Snippet, By Indication
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Proton Therapy Market, By Set up Type, 2020-2032 (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Single Room
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Multiple Room
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Proton Therapy Market, By Indication, 2020-2032 (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Head & Neck Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Sarcoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Pediatric Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Gastro-intestinal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Prostate Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Lung Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Proton Therapy Market, By Region, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region 2021-2032
• North America
  • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
• Middle East
  • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country, 2020-2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, By Set up Type, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Indication, 2020-2032, (USD Mn)
  • Market Size and Forecast, By Country/Region, 2020-2032, (USD Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

• Company Profiles
  • Hitachi Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ion Beam Applications SA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mevion Medical Systems
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mitsubishi Electric Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Provision Healthcare
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Protom International
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Sumitomo Heavy Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Varian Medical Systems, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Optivus Proton Therapy, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Advanced Oncotherapy plc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies

8. Section

• References
• Research Methodology
• About us and Sales Contact